These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11454170)

  • 21. Structure-activity relationship of for-L-Met L-Leu-L-Phe-OMe analogues in human neutrophils.
    Cavicchioni G; Fraulini A; Falzarano S; Spisani S
    Bioorg Chem; 2006 Oct; 34(5):298-318. PubMed ID: 16919307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, conformation, and biological activity of two fMLP-OMe analogues containing the new 2-[2'-(methylthio)ethyl]methionine residue.
    Torrini I; Paglialunga Paradisi M; Pagani Zecchini G; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Traniello S; Spisani S
    Biopolymers; 1997 Oct; 42(4):415-26. PubMed ID: 9283291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-peptide/beta-sulfonamidopeptide hybrids: analogs of the chemotactic agent for-Met-Leu-Phe-OMe.
    Giordano C; Lucente G; Masi A; Paradisi MP; Sansone A; Spisani S
    Bioorg Med Chem; 2006 Apr; 14(8):2642-52. PubMed ID: 16356729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils.
    Cavicchioni G; Fraulini A; Turchetti M; Varani K; Falzarano S; Pavan B; Spisani S
    Eur J Pharmacol; 2005 Apr; 512(1):1-8. PubMed ID: 15814083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological evaluation of new active For-Met-Leu-Phe-OMe analogues containing para-substituted Phe residues.
    Mollica A; Feliciani F; Stefanucci A; Costante R; Lucente G; Pinnen F; Notaristefano D; Spisani S
    J Pept Sci; 2012 Jun; 18(6):418-26. PubMed ID: 22528501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and activity of HCO-Met-Leu-Phe-OMe analogues containing beta-alanine or taurine at the central position.
    Giordano C; Lucente G; Nalli M; Pagani Zecchini G; Paglialunga Paradisi M; Varani K; Spisani S
    Farmaco; 2003 Nov; 58(11):1121-30. PubMed ID: 14572863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic formyl tripeptide chemoattractants: a C(alpha,alpha)-dialkylated, amphiphilic glycyl residue at position 1.
    Witkowska R; Zabrocki J; Spisani S; Falzarano MS; Toniolo C; Formaggio F
    J Pept Sci; 2003 Jun; 9(6):354-60. PubMed ID: 12846481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotactic peptide analogues. Synthesis and chemotactic activity of N-formyl-Met-Leu-Phe analogues containing (S)-phenylalaninol derivatives.
    Zecchini GP; Paradisi MP; Torrini I; Spisani S
    Arch Pharm (Weinheim); 1995 Sep; 328(9):673-6. PubMed ID: 7487425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New chemotactic dimeric peptides show high affinity and potency at the human formylpeptide receptor.
    Spisani S; Fraulini A; Varani K; Falzarano S; Cavicchioni G
    Eur J Pharmacol; 2007 Jul; 567(1-2):171-6. PubMed ID: 17481605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modified chemotactic peptides: synthesis and biological activity of HCO-Met-delta ZLeu-delta ZPhe-OMe.
    Pagani Zecchini G; Torrini I; Paglialunga Paradisi M; Lucente G; Spisani S
    Farmaco; 1994 Nov; 40(11):739-42. PubMed ID: 7832975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A hydrophilic residue at position 2 can improve specific biological responses in fMLP-OMe analogs.
    Cavicchioni G; Spisani S
    J Pept Res; 2001 Sep; 58(3):257-62. PubMed ID: 11576332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modified chemotactic peptides: synthesis, crystal conformation, and activity of For-Hse(Me)-Leu-Phe-OMe.
    Torrini I; Pagani Zecchini G; Paglialunga Paradisi M; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Traniello S; Spisani S
    Biopolymers; 1994 Jan; 34(1):1-9. PubMed ID: 8110962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and chemotactic activity of the fMLP analog HCO-Hmb-Leu-Phe-OMe.
    Zecchini GP; Paradisi MP; Torrini I; Lucente G; Traniello S; Spisani S
    Arch Pharm (Weinheim); 1993 Aug; 326(8):461-5. PubMed ID: 8215843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of neutrophil phospholipase C activity and cyclic AMP levels by fMLP-OMe analogues.
    Ferretti ME; Nalli M; Biondi C; Colamussi ML; Pavan B; Traniello S; Spisani S
    Cell Signal; 2001 Apr; 13(4):233-40. PubMed ID: 11306240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotactic peptide analogues. Centrally constrained chemotactic N-formyltripeptides: synthesis, conformation, and activity of two new analogues.
    Pagani Zecchini G; Paglialunga Paradisi M; Torrini I; Lucente G; Mastropietro G; Paci M; Spisani S
    Arch Pharm (Weinheim); 1996 Dec; 329(12):517-23. PubMed ID: 9038418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Properties of a novel chemotactic esapeptide, an analogue of the prototypical N-formylmethionyl peptide.
    Cavicchioni G; Turchetti M; Varani K; Falzarano S; Spisani S
    Bioorg Chem; 2003 Aug; 31(4):322-30. PubMed ID: 12877881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and properties of chemotactic peptide analogs. I. Crystal structure and molecular conformation of HCO-Met-leu-Ain-OMe.
    Gavuzzo E; Lucente G; Mazza F; Zecchini GP; Paradisi MP; Pochetti G; Torrini I
    Int J Pept Protein Res; 1991 Apr; 37(4):268-76. PubMed ID: 1894442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of the cyclopropyl group on the conformation of chemotactic formyl tripeptides.
    Headley AD; Ganesan R; Nam J
    Bioorg Chem; 2003 Apr; 31(2):99-108. PubMed ID: 12729567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formyl peptide chemoattractants. Synthesis and chemotactic activity.
    Falcomer C; Vertuani G; Boggian M; Scatturin A; Spisani S; Cavalletti T; Traniello S
    Farmaco Sci; 1987 Nov; 42(11):815-22. PubMed ID: 3443176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotactic tripeptides incorporating at position 2 alpha-aminoacid residues with unsaturated side chains.
    Lucente G; Paradisi MP; Giordano C; Sansone A; Torino D; Spisani S
    Amino Acids; 2008 Aug; 35(2):329-38. PubMed ID: 18163179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.